Cognatio Pharmaceuticals Private Limited

Cognatio Pharmaceuticals Private Limited - business services in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U74999MH2022PTC389267 Incorporated 25 August 2022 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company business services MSME · Micro
Data last updated
Revenue · FY 2024
₹43.15 Lakh
▲ 908% YoY
Net profit · FY 2024
₹59,390
Net margin 1.4%
EBITDA · FY 2024
₹84,925
EBITDA margin 2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Cognatio Pharmaceuticals Private Limited

Data last updated:

Cognatio Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 25 August 2022.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2022PTC389267.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ramegowda Marur Manje Gowda (Managing Director) and Chaithra Ramegowda.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Room No 2 Laxmi Store Annaya Chawl Opp. Bmc School Laxmi Nagar Dhrkhadi Dahisar East, Mumbai, Maharashtra, India – 400068.

As per the financials filed for FY 2024, the company reported a revenue of ₹43.15 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹59,390 (net margin 1.4%) and EBITDA of ₹84,925 (EBITDA margin 2%).

Cognatio Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-22-0035028). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999MH2022PTC389267
Registration Number 389267
Incorporation Date 25 August 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-22-0035028

Recognitions & Rankings of Cognatio Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-KR-22-0035028

Contact details

Cognatio Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.

  • Registered Address
    Room No 2 Laxmi Store Annaya Chawl Opp. Bmc School Laxmi Nagar Dhrkhadi Dahisar East, Mumbai, Maharashtra, India – 400068
  • Industry
    Business Services, Other Services, Miscellaneous Business Activities
Comprehensive company report
Cognatio Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Cognatio Pharmaceuticals is human health and social work activities. In detail, this covers human health activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHuman health and social work activities86Human health activities

To see the full business activity and turnover split of Cognatio Pharmaceuticals Private Limited, buy the company report.

Financials of Cognatio Pharmaceuticals Private Limited

FY 2025 filings available

Cognatio Pharmaceuticals Private Limited reported revenue of ₹43.15 Lakh (up 908% YoY) for FY 2024.

Revenue · FY 2024
₹43.15 Lakh ▲ 908%
Net profit · FY 2024
₹59,390 margin 1.4%
EBITDA · FY 2024
₹84,925 margin 2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 908%
EBITDA CAGR growth
1 year
▲ 93%

Revenue rose 908% in the latest year. EBITDA rose 93% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹84,925
Profit Before Tax
Tax Expense
Net Profit (PAT)₹59,390
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23
Profitability
EBITDA Margin2%
Net Profit Margin1.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Cognatio Pharmaceuticals Private Limited, buy the company report.

Board of directors of Cognatio Pharmaceuticals Private Limited

Cognatio Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Ramegowda Marur Manje GowdaManaging Director25 Aug 20224 Years 2 MonthsCurrent
Chaithra RamegowdaDirector25 Aug 20224 Years 2 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Cognatio Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Cognatio Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Cognatio Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Chaithra Ramegowda was appointed as Director on 25 Aug 2022.

AGM
Cognatio Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cognatio Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Chaithra Ramegowda was appointed as Director.
Appointed
Ramegowda Marur Manje Gowda was appointed as Managing Director.
Incorporation
25 Aug 2022
Cognatio Pharmaceuticals Private Limited was registered on 25 Aug 2022 with Roc Mumbai & aged 4 years 2 months as per MCA records.

Frequently asked questions

Cognatio Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 25 August 2022 (4+ years old) and is registered under CIN U74999MH2022PTC389267.

Cognatio Pharmaceuticals has 2 current directors:

The latest financial statements of Cognatio Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Cognatio Pharmaceuticals is U74999MH2022PTC389267. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Cognatio Pharmaceuticals was incorporated on 25 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.

Chaithra Ramegowda was appointed as Director on 25 Aug 2022. Ramegowda Marur Manje Gowda was appointed as Managing Director on 25 Aug 2022.

Yes, Cognatio Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-22-0035028).

The registered office of Cognatio Pharmaceuticals is at Room No 2 Laxmi Store Annaya Chawl Opp. Bmc School Laxmi Nagar Dhrkhadi Dahisar East, Mumbai, Maharashtra, India – 400068.

Cognatio Pharmaceuticals operates in the business services industry, in the other services segment.

The compliance status of Cognatio Pharmaceuticals is compliant as of 21 September 2026. The company is actively filing with the Registrar of Companies.